Drug Shortage Report for ACT AMLODIPINE

Last updated on 2023-04-28 History
Report ID 184204
Drug Identification Number 02297485
Brand name ACT AMLODIPINE
Common or Proper name AMLODIPINE 5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) AMLODIPINE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-07
Estimated end date 2023-03-20
Actual end date 2023-04-27
Shortage status Resolved
Updated date 2023-04-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-04-28 English Compare
v6 2023-04-26 French Compare
v5 2023-04-26 English Compare
v4 2023-02-16 French Compare
v3 2023-02-16 English Compare
v2 2023-02-09 French Compare
v1 2023-02-09 English Compare

Showing 1 to 7 of 7